Skip to main content
. 2021 Aug 2;129(6):669–683. doi: 10.1161/CIRCRESAHA.120.318577

Figure 5.

Figure 5.

SRSF4 (serine/arginine splicing factor 4) KO mice show an increase in hypertrophy and cardiac expression of hypertrophic markers and known GR (glucocorticoid receptor) targets following DEX treatment.A and B, Echocardiography analysis of left ventricular (LV) wall thickness (A), and heart weight/body weight (B) of SRSF4 KO and control mice following 2 wk treatment with DEX (15 mg/100 g BW) or no treatment. Expression of ANF (C), brain natriuretic peptide (BNP) (D), Fkbp5 (E), and Gliz (F) was analyzed by quantitative real-time polymerase chain reaction. Data are shown as mean±SEM. Symbols represent individual animals. ***P<0.001 DEX (green) vs No DEX (violet). †P<0.05, SRSF4 KO vs control, †††P<0.001 SRSF4 KO vs control. Two-way ANOVA followed by Bonferroni correction.